| Title: |
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians’ and nurses’ points of view |
| Authors: |
Cingolani, A; Tavelli, A; De Benedittis, S; Mastrorosa, I; Muccini, C; Bini, T; Carraro, A; Compagno, M; Mazzitelli, M; Guastavigna, M; Cernuschi, M; Torti, C; Antinori, A; d'Arminio Monforte, A; null, null; Antinori, S; Castagna, A; Cauda, R; Di Perri, G; Girardi, E; Iardino, R; Lazzarin, A; Marchetti, G C; Mussini, C; Quiros-Roldan, E; Sarmati, L; Suligoi, B; von Schloesser, F; Viale, P; Ceccherini-Silberstein, F; Cozzi-Lepri, A; Di Biagio, A; Gori, A; Lo Caputo, S; Marchetti, G; Maggiolo, F; Puoti, M; Perno, C F; Bai, F; Bandera, A; Bonora, S; Calcagno, A; Canetti, D; Cervo, A; Cinque, P; Gagliardini, R; Giacomelli, A; Gianotti, N; Guaraldi, G; Lanini, S; Lapadula, G; Lichtner, M; Lai, A; Madeddu, G; Malagnino, V; Mondi, A; Mazzotta, V; Nozza, S; Piconi, S; Pinnetti, C; Quiros Roldan, E; Rossotti, R; Rusconi, S; Santoro, M M; Saracino, A; Spagnuolo, V; Squillace, N; Svicher, V; Taramasso, L; Vergori, A; Fanti, I; Giotta, M; Marelli, C; Rodano', A; Cosmaro, L; Perziano, A; Calvino, V; Russo, D; Farinella, M; Policek, N; Del Negro, V L; Augello, M; Carrara, S; Graziano, S; Prota, G; Truffa, S; Vincenti, D; Rovito, R; Giacometti, A; Costantini, A; Barocci, V; Santoro, C; Milano, E; Comi, L; Suardi, C; Badia, L; Cretella, S; Erne, E M; Pieri, A; Focà, E; Minardi, C; Menzaghi, B; Abeli, C; Chessa, L; Pes, F; Maggi, P; Alessio, L; Nunnari, G; Celesia, B M; Vecchiet, J; Falasca, K; Pan, A; Dal Zoppo, S; Segala, D; Di Pietro, M A; Costa, C; Ferrara, S; Bassetti, M; Pontali, E; Blanchi, S; Bobbio, N; Mazzarello, G; Fondaco, L; Molteni, C; Canavesi, G; Pellicanò, G; Rizzardini, G; Bono, V; Cossu, M V; Lolatto, R; Moioli, M C; Pezzati, L; Diotallevi, S; Tincati, C; Menozzi, M; Bonfanti, P; Sangiovanni, V; Gentile, I; Esposito, V; Coppola, N; Fusco, F M; Di Filippo, G; Rizzo, V; Sangiovanni, N; Martini, S; Cattelan, A M; Leoni, D; Cascio, A; Trizzino, M; Francisci, D; Schiaroli, E; Parruti, G; Sozio, F; Messeri, D; Bonelli, S I; Lazzaretti, C; Corsini, R; Mastroianni, C; Latini, A; Lamonica, S; Capozzi, M; Camici, M; Rivano Capparuccia, M; Iaiani, G; Stingone, C; Gianserra, L; Paulicelli, J; Plazzi, M M; d'Ettore, G; Fusto, M; Coledan, I; De Vito, A; Fabbiani, M; Montagnani, F; Franco, A; Del Vecchio, R Fontana; Pasticci, B M; Di Giuli, C; Orofino, G C; Calleri, G; Accardo, G; Tascini, C; Londero, A; Battagin, G; Nicolè, S; Starnini, G; Dell'Isola, S |
| Contributors: |
Cingolani, A; Tavelli, A; De Benedittis, S; Mastrorosa, I; Muccini, C; Bini, T; Carraro, A; Compagno, M; Mazzitelli, M; Guastavigna, M; Cernuschi, M; Torti, C; Antinori, A; d'Arminio Monforte, A; Null, N; Antinori, S; Castagna, A; Cauda, R; Di Perri, G; Girardi, E; Iardino, R; Lazzarin, A; Marchetti, Gc; Mussini, C; Quiros-Roldan, E; Sarmati, L; Suligoi, B; von Schloesser, F; Viale, P; Ceccherini-Silberstein, F; Cozzi-Lepri, A; Di Biagio, A; Gori, A; Lo Caputo, S; Marchetti, G; Maggiolo, F; Puoti, M; Perno, Cf; Bai, F; Bandera, A; Bonora, S; Calcagno, A; Canetti, D; Cervo, A; Cinque, P; Gagliardini, R; Giacomelli, A; Gianotti, N; Guaraldi, G; Lanini, S; Lapadula, G; Lichtner, M; Lai, A; Madeddu, G; Malagnino, V; Mondi, A; Mazzotta, V; Nozza, S; Piconi, S; Pinnetti, C; Quiros Roldan, E; Rossotti, R; Rusconi, S; Santoro, Mm; Saracino, A; Spagnuolo, V; Squillace, N; Svicher, V; Taramasso, L; Vergori, A; Fanti, I; Giotta, M |
| Publisher Information: |
Oxford University Press |
| Publication Year: |
2024 |
| Collection: |
Universitá degli Studi di Roma "Tor Vergata": ART - Archivio Istituzionale della Ricerca |
| Subject Terms: |
Settore MED/07; Settore MEDS-03/A - Microbiologia e microbiologia clinica |
| Description: |
Background: Implementation level of long-acting injectable agents cabotegravir/rilpivirine (LAI CAB/RPV) for human immunodeficiency virus (HIV) treatment in Italy is still not known. The aim of this study is to identify the status of implementation of LAI CAB-RPV and its barriers. Materials and methods: A cross-sectional online survey was conducted among infectious diseases (ID) physicians and nurses belonging to the ICONA network in Italy. Three validate 4-items measures were used: Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM) and Feasibility of Intervention Measure (FIM). Results: Out of 61 ICONA centres, 38 (62%) completed the survey: 57.9% were academic centres, 42.1% were hospital-based. In total, 104 respondents were ID physicians (57.4%), 77 were nurses (42.5%); 4.5% of all PWH followed at the 38 centres started LAI CAB/RPV at time of study. Centres taking care of >1000 PWH reported 95% application of procedures for LA implementation, higher than other centres (P= 0.009). Mean score of AIM was (16.0, standard deviation, SD, 3.3), of IAM (16.0, SD 3.0) and FIM (16.0, SD 2.9). A linear correlation was found between AIM and the number of people with HIV who started LAI CAB/RPV (25–50 versus |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| Relation: |
info:eu-repo/semantics/altIdentifier/pmid/39140512; info:eu-repo/semantics/altIdentifier/wos/WOS:001291277600001; volume:79; issue:10; firstpage:2662; lastpage:2667; numberofpages:6; journal:JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY; https://hdl.handle.net/2108/394463 |
| DOI: |
10.1093/jac/dkae273 |
| Availability: |
https://hdl.handle.net/2108/394463; https://doi.org/10.1093/jac/dkae273 |
| Rights: |
info:eu-repo/semantics/openAccess ; license:Copyright dell'editore ; license uri:iris.publisher |
| Accession Number: |
edsbas.358398DC |
| Database: |
BASE |